肝细胞癌微血管侵犯的研究进展  

Research progress of microvascular invasion in hepatocellular carcinoma

作　　者：何涛[1] 邹婕妤 孙科[1] 雷婷婷 徐琳[1] 李广阔 He Tao;Zou Jieyu;Sun Ke;Lei Tingting;Xu Lin;Li Guangkuo(Department of Hepatobiliary Surgery,Second People's Hospital of Chengdu,Chengdu 610017,China;The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)

机构地区：[1]成都市第二人民医院肝胆外科,成都610017 [2]重庆医科大学附属第二医院,重庆400010

出　　处：《中华肝脏病杂志》2022年第8期899-904,共6页Chinese Journal of Hepatology

摘　　要：肝细胞癌(HCC)是一种具有较强侵袭性的消化系统肿瘤。现有多项研究证实微血管侵犯(MVI)是HCC术后早期复发及预后不良的独立危险因素。诊断MVI的金标准为病理学检查。现从MVI概述、预后、术前预测及治疗方案进行文献综述。Hepatocellular carcinoma(HCC)is a kind of highly aggressive tumor of the digestive system.Several studies have confirmed that microvascular invasion(MVI)is an independent risk factor for early recurrence and poor prognosis of HCC after surgery.Currently,pathological examination is the gold standard for diagnosing MVI.This paper summarizes concept,prognosis,preoperative prediction and treatment plan based on literature review of MVI in HCC.

关 键 词：肝细胞癌 微血管侵犯 肝切除术 危险因素 治疗 

分 类 号：R735.7[医药卫生—肿瘤]